-
To some, the term genital emergencies recalls junior high school with the typical adolescent male humor of the time. But to a physician, this term describes a collection of disorders with potential implications to reproductive, sexual, and urologic function. Since many of these disorders are progressive, with the potential to cause increasing injury with the passage of time, early recognition and treatment are important in minimizing damage. In this two-part series, the author discusses the current literature and makes treatment recommendations for both the common and rare emergent conditions that can affect the male genitalia.
-
-
-
Chronic fatigue syndrome (CFS) is common in community practice and it has been speculated that it is the result of chronic immune proliferation or infection. In a review of Surveillance, Epidemiology, and End Results registry data, coupled with Medicare claims data, an association of CFS with non-Hodgkin lymphoma is clearly demonstrated.
-
A colonic cleansing preparation has been approved by the FDA. The preparation contains sodium picosulfate, magnesium oxide, and citric acid and forms sodium picosulfate and magnesium citrate upon reconstitution (PSMC). The preparation has been available outside the United States since 1980 and is manufactured and marketed by Ferring Pharmaceuticals as Prepopik.
-
The 12-lead ECG shown above was obtained from a 50-year-old woman with chest pain. What two major conclusions should be reached regarding ECG interpretation of this tracing?
-
-
Prevalent left bundle branch block (LBBB) in cardiovascular disease (CVD)-free women and either LBBB or right bundle branch block (RBBB) in women with CVD were significant predictors of coronary heart disease (CHD) death. In women with LBBB, ST segment J-point depression in lead aVL was also a strong independent predictor of CHD death.
-
When One Antihypertensive Med is Not Enough: Which Combination?; Early Identification of COPD Exacerbations; Vitamin D for Osteoarthritis: NOT
-
Apixaban approval; new dental clinical practice guideline; apixaban for VTE; aspirin resistance; tamoxifen treatment; and FDA actions.
